Current Net Margin
-304.25%
Recursion Pharmaceuticals, Inc. currently has a net profit margin of -304.25%.
Financial Fundamentals
RXRX • Quarterly Data • 5Y View
Historical Margin Data
| Date | Rev ($B) | NI ($B) | Net Margin | Change (bps) |
|---|---|---|---|---|
| 2025-12-31 | 0.04 | -0.11 | -304.25% | ▲283107 |
| 2025-09-30 | 0.01 | -0.16 | -3135.32% | ▼223548 |
| 2025-06-30 | 0.02 | -0.17 | -899.84% | ▲47342 |
| 2025-03-31 | 0.01 | -0.20 | -1373.26% | ▲259274 |
| 2024-12-31 | 0.00 | -0.18 | -3965.99% | ▼359917 |
| 2024-09-30 | 0.03 | -0.10 | -366.82% | ▲31035 |
| 2024-06-30 | 0.01 | -0.10 | -677.17% | ▲12 |
| 2024-03-31 | 0.01 | -0.09 | -677.29% | ▲19805 |
| 2023-12-31 | 0.01 | -0.09 | -875.34% | ▲4544 |
| 2023-09-30 | 0.01 | -0.09 | -920.78% | ▼22428 |
| 2023-06-30 | 0.01 | -0.08 | -696.50% | ▼15812 |
| 2023-03-31 | 0.01 | -0.07 | -538.38% | ▼11799 |
| 2022-12-31 | 0.01 | -0.06 | -420.39% | ▲4269 |
| 2022-09-30 | 0.01 | -0.06 | -463.07% | ▲39358 |
| 2022-06-30 | 0.01 | -0.07 | -856.66% | ▲19975 |
| 2022-03-31 | 0.01 | -0.06 | -1056.41% | ▲154091 |
| 2021-12-31 | 0.00 | -0.06 | -2597.32% | ▼70020 |
| 2021-09-30 | 0.00 | -0.05 | -1897.12% | ▼16108 |
| 2021-06-30 | 0.00 | -0.04 | -1736.04% | ▼50736 |
| 2021-03-31 | 0.00 | -0.03 | -1228.68% | ▼21864 |
| 2020-12-31 | 0.00 | -0.03 | -1010.04% | ▲175945 |
| 2020-09-30 | 0.00 | -0.02 | -2769.49% | — |
| 2020-06-30 | 0.00 | -0.02 | — | — |
| 2020-03-31 | 0.00 | -0.02 | — | — |
* Basis Point (bps) change measures sequential efficiency shifts. 100 bps = 1.00% Margin change.